Seoul Pharma Co. Ltd (018680) — Strategic Asset Allocation Index
Seoul Pharma Co. Ltd (018680) has a Strategic Asset Allocation Index of 83.5% as of March 2025. Strategic assets (PP&E of ₩33.40 Billion plus long-term investments of ₩-) total ₩33.40 Billion, measured against net assets of ₩40.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Seoul Pharma Co. Ltd (018680) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Seoul Pharma Co. Ltd Strategic Asset Allocation Index (2012–2024)
This chart shows how Seoul Pharma Co. Ltd's Strategic Asset Allocation Index has evolved across 13 annual periods from 2012 to 2024. As of March 2025, the index stands at 83.5%, representing strategic assets of ₩33.40 Billion against net assets of ₩40.01 Billion KRW. For live market cap and overall valuation, see Seoul Pharma Co. Ltd (018680) market capitalisation.
Annual Strategic Asset Allocation Index for Seoul Pharma Co. Ltd (2012–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Seoul Pharma Co. Ltd from 2012 to 2024, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 018680 book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 84.3% | ₩33.86 Billion | ₩33.86 Billion | ₩- | ₩40.17 Billion | ▲ +3.0 pp |
| 2023 | 81.2% | ₩31.33 Billion | ₩31.33 Billion | ₩- | ₩38.56 Billion | ▼ -5.4 pp |
| 2022 | 86.6% | ₩30.68 Billion | ₩30.68 Billion | ₩- | ₩35.42 Billion | ▼ -93.0 pp |
| 2021 | 179.6% | ₩34.05 Billion | ₩34.05 Billion | ₩- | ₩18.96 Billion | ▲ +56.7 pp |
| 2020 | 123.0% | ₩35.48 Billion | ₩35.48 Billion | ₩- | ₩28.85 Billion | ▼ -22.6 pp |
| 2019 | 145.5% | ₩41.40 Billion | ₩41.40 Billion | ₩- | ₩28.45 Billion | ▲ +62.8 pp |
| 2018 | 82.7% | ₩41.60 Billion | ₩41.28 Billion | ₩319.53 Million | ₩50.31 Billion | ▲ +2.8 pp |
| 2017 | 79.9% | ₩43.04 Billion | ₩42.76 Billion | ₩278.90 Million | ₩53.86 Billion | ▼ -43.6 pp |
| 2016 | 123.5% | ₩51.97 Billion | ₩51.43 Billion | ₩539.40 Million | ₩42.07 Billion | ▼ -19.7 pp |
| 2015 | 143.2% | ₩48.02 Billion | ₩47.52 Billion | ₩493.99 Million | ₩33.53 Billion | ▼ -12.2 pp |
| 2014 | 155.4% | ₩48.32 Billion | ₩47.86 Billion | ₩456.88 Million | ₩31.10 Billion | ▲ +154.1 pp |
| 2013 | 1.3% | ₩421.00 Million | ₩- | ₩421.00 Million | ₩32.25 Billion | ▼ -0.2 pp |
| 2012 | 1.5% | ₩391.00 Million | ₩- | ₩391.00 Million | ₩25.38 Billion | — |